The chances of BAL revising its revenue guidance upwards has become very real and high. It should be at $10-11 before SAMR grant.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game